Aventis Pharma Q1 PAT seen at Rs 36.3 cr: Motilal Oswal

Published on Sat, Jul 04, 2009 at 16:30 |  Source : Moneycontrol.com

Updated at Sat, Jul 04, 2009 at 16:38  

4026 Investors following Aventis Pharma. Share this News with them.
0
0
Share on Tumblr
Aventis Pharma Q1 PAT seen at Rs 36.3 cr: Motilal Oswal

ALSO READ

Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Aventis Pharma 's June quarter sales are expected to go down by 6.3% to Rs 233.1 crore on YoY basis.

The company's adjusted PAT (profit after tax) is expected to go down by 13.2% to Rs 36.3 crore on YoY basis.

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com